Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04409236 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

StatusActive, Not Recruiting
PhaseNot applicable
Started2021-07-19
View on ClinicalTrials.gov ↗

Amendment history

2026-09-02
Study Status, Sponsor/Collaborators, Study Design, Outcome Measures, Document Section, Participant Flow, Baseline Characteristics, Outcome Measures (Results), Adverse Events, More Information v22
Phase changed: Phase 3 → not applicable
Results posted: 2026-09-04
Secondary endpoints2 entries, revised
Number of participantsParticipants withWith 30-day cigaretteCigarette smokingSmoking cessationCessation at 36 monthsMonths. Number of participantsParticipants withWith 30-day cigaretteCigarette smokingSmoking cessationCessation at 63 monthsMonths.
Primary endpoints1 entry, revised
Number of participantsParticipants withWith 30-day cigaretteCigarette smokingSmoking cessationCessation at 12 monthsMonths.
2025-09-15
3 amendments v19-v21
3 re-verifications since 2025-01-31, no change to tracked fields
2024-07-03
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations, Document Section v18
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2025-05-31→2025-09-11
Completion date2026-05-31→2026-09-11
Enrollment targetestimated 422→confirmed 427
Study sitesdetails revised at 1 of 1 site
2023-12-15
Study Identification, Study Status v17
Re-verified, no change to tracked fields
2023-05-12
Study Status, Conditions, Eligibility v16
Eligibility criteria-212 characters
Inclusion Criteria: Age 18 or older Diagnosed with cancer within the past 1224 months or currently receiving or planning to receive cancer [...] on Not providing email, phone number(s), and mailing address Current use of Food and Drug Administration (FDA)-approved quit smoking medications: nicotine patch, nicotine gum, nicotine lozenge, nicotine nasal spray, nicotine inhaler, Chantix (varenicline), or Wellbutrin (Zyban/bupropion)
Show 15 earlier versions
2023-03-22
Study Status v15
Re-verified, no change to tracked fields
2022-09-20
Study Status v14
Primary completion date2024-05-31→2025-05-31
Completion date2025-05-31→2026-05-31
2022-03-08
Study Status, Sponsor/Collaborators, Contacts/Locations v13
Study sites2→1
Collaborators2 to 3 entries
Memorial Sloan Kettering Cancer Center
2021-10-18
Study Status v12
Re-verified, no change to tracked fields
2021-07-20
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v11
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-06→confirmed 2021-07-19
Study sitesdetails revised at 2 of 2 sites
2021-06-18
Study Status v10
Start date2021-06-18→2021-06
2021-05-21
Study Status v9
Start date2021-05-15→2021-06-18
2021-04-13
Study Status v8
Primary completion date2024-06-30→2024-05-31
Completion date2025-06-30→2025-05-31
Start date2021-05-05→2021-05-15
2021-04-05
Study Status v7
Start date2021-04-05→2021-05-05
2021-03-05
Study Status v6
Start date2021-03-05→2021-04-05
2021-02-05
Study Status v5
Start date2021-02-04→2021-03-05
2021-01-04
Study Status v4
Start date2021-01-04→2021-02-04
2020-12-01
Study Status v3
Start date2020-12-01→2021-01-04
2020-07-29
2 amendments v1-v2
2 re-verifications since 2020-06-23, no change to tracked fields
2020-05-29
Original filing
This phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting and staying tobacco-free, and scientifically-based recommendations for how to select medications that aid in smoking cessation.
Trial Details
NCT Number NCT04409236
Lead Sponsor Fred Hutchinson Cancer Center
Collaborators: National Cancer Institute (NCI), American Cancer Society, Inc., Memorial Sloan Kettering Cancer Center
Conditions Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Enrollment 427 participants
Start Date 2021-07-19
Primary Completion 2025-09-11 (estimated)
Study Completion 2026-09-11 (estimated)
Updated on ClinicalTrials.gov 2026-09-04